Curcumin interferes with a number of cellular pathways (in vivo and in vitro) in prostate cancer, including mitogen-activated protein kinase (MAPK), epidermal growth factor receptor (EGFR), and nuclear factor κ (NFκB) [19]. Here, EGFR is linked to prostate carcinoma.